secwatch / observer
8-K filed October 3, 2023, 7:59 PM ET ticker LITS CIK 0001262104
other material confidence high sentiment neutral materiality 0.75

MEI Pharma adopts poison pill after Anson/Cable Car accumulate ~19.9% stake

Lite Strategy, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Lite Strategy, Inc.: Board approved Series A Certificate of Designation setting forth rights, powers, and preferences of Series A Preferred Shares (effective 2023-10-01).

Change
charter amendment
Effective
2023-10-01
Exact text from the filing
on October 1, 2023, the Board approved the Series A Certificate of Designation. The Series A Certificate of Designation sets forth the rights, powers, and preferences of the Series A Preferred Shares.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Lite Strategy, Inc. entered into Rights Agreement with Computershare, Inc. (effective 2023-10-01).

Action
entry
Counterparty
Computershare, Inc.
Effective
2023-10-01
Exact text from the filing
On October 1, 2023, the Board of Directors (the “Board”) of MEI Pharma, Inc., a Delaware corporation (the “Company”), approved and adopted a Rights Agreement, dated as of October 1, 2023 (the “Rights Agreement”), by and between the Company and Computershare, Inc., as Rights Agent (the “Rights Agent”).
View on SEC.gov

59 governance changes filed in the last 30 days. Browse all governance changes →

Lite Strategy, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-249423
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.